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Background: Selective arterial radioembolisation of liver tumours has increased, because of encouraging efficacy
reports; however, therapeutic parameters used in external beam therapy are not applicable for understanding and
predicting potential toxicity and efficacy, necessitating further studies of the physical and biological characteristics
of radioembolisation. The aim was to characterise heterogeneity in the distribution of microspheres on a
therapeutically relevant geometric scale considering the range of yttrium-90 (90Y) β-particles.
Methods: Two patients with intrahepatic cholangiocarcinoma, marginally resectable, were treated by selective
arterial embolisation with 90Y resin microspheres (SIRTEX®), followed 9 days post-infusion by resection, including
macroscopic tumour tissue and surrounding normal liver parenchyma. Formalin-fixed, sectioned resected tissues
were exposed to autoradiographic films, or tissue biopsies of various dimensions were punched out for activity
measurements and microscopy.
Results: Autoradiography and activity measurements revealed a higher activity in tumour tissue compared to
normal liver parenchyma. Heterogeneity in activity distribution was evident in both normal liver and tumour tissue.
Activity measurements were analysed in relation to the sample mass (5 to 422 mg), and heterogeneities were
detected by statistical means; the larger the tissue biopsies, the smaller was the coefficient of variation. The
skewness of the activity distributions increased with decreasing biopsy mass.
Conclusions: The tissue activity distributions in normal tissue were heterogeneous on a relevant geometric scale
considering the range of the ionising electrons. Given the similar and repetitive structure of the liver parenchyma,
this finding could partly explain the tolerance of a relatively high mean absorbed dose to the liver parenchyma
from β-particles.
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Primary and metastatic liver tumours present a signifi-
cant clinical problem, when radical surgery, the only
curative option, is not possible because of extensive
growth in connection with vital structures, even without
extra-hepatic growth. Chemotherapy has limited efficacy
[1-3], and external beam radiotherapy, including stereo-
tactic techniques, is hampered by a normal liver tissue* Correspondence: jonas.hogberg@radfys.gu.se
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in any medium, provided the original work is ptolerance that is less than needed for tumour eradication
[4,5]. Other techniques used for local destruction of liver
tumours include radiofrequency or ultrasound ablation
and are moderately successful [6-8]; thus, new treatment
modalities are urgently needed. Because liver malignancies
are supplied mainly from the hepatic artery, in contrast to
portal vein supply to the liver parenchyma [9], selective
intra-arterial interventions have been used, including
arterial chemoembolisation [10] and radioembolisation.
The evidence favouring one technique over the other is
weak. However, it seems clear that with present radioembo-
lisation techniques using yttrium-90-labelled (90Y-labelled)s an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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tumour reduction can be achieved with relatively little
radiation-induced hepatic damage in spite of mean liver
doses far exceeding those tolerated in external beam ther-
apy [9,11,12]. Knowledge of the physical and biological
background is meagre; not least the explanation of the
relatively high tolerance for ionising radiation of the nor-
mal liver tissue, but it is probably related to the low dose
rate of radionuclide therapy and dose heterogeneity, allow-
ing for regeneration from low-dose regions in the normal
liver parenchyma.
The possible sparing effect of the low dose rate has
been theoretically investigated by Cremonesi et al. [13].
They showed a minor sparing effect in regard to bio-
logically effective doses (BEDs). In contrast, large non-
uniform microsphere distributions have been observed
in surgically removed tissue samples after radioembolisa-
tion [14-17]. However, no clear quantitative description
of the non-uniformity has been presented from this lim-
ited number of studies and the main focus has been
tumour tissue rather than normal liver parenchyma.
Despite the unknown small-scale distribution of micro-
spheres, Gulec et al. presented a detailed Monte Carlo
modelling approach for performing small-scale dosim-
etry [18]. They used millions of closed-packed hexagonal
lobules (radius 0.6 mm and length 1.5 mm) to model the
liver parenchyma, and the microspheres were uniformly
distributed in the portal tracts in the corners of the lob-
ules. Despite the long range of 90Y electrons (max range,
11 mm; mean range, 2.5 mm) [19], a more than twofold
difference in the absorbed doses to the fine structures
was obtained; the cross-irradiation would only partly
smooth the dose distribution. Therefore, it can be antici-
pated that a variable distribution of microspheres in the
portal tracts will create a primarily non-uniform dose
distribution in the liver parenchyma.
To investigate the question of heterogeneity, here we
evaluated activity distributions on biopsies taken from
resected tissue samples pre-surgically treated with resin
microspheres (SIR-Spheres®).Methods
Patients
Two patients were selected with cholangiocarcinoma
that was confined to the liver but only marginally resect-
able because of proximity to critical vascular and biliary
structures. They underwent radioembolisation followed
by marginal resection, with the rationale to reduce the
risk of local recurrence at the resection margins.
The study was carried out in compliance with the
Declaration of Helsinki and has been approved by the
Regional Ethical Review Board in Gothenburg, Sweden.
Both patients have given written consent to the treatment.Patient 1 (Pt 1), a female age 33 years, had a tumour
mass of approximately 770 and 180 g, in the left and right
liver lobes, respectively, with normal liver tissue of
approximately 100 and 1,200 g in the respective lobes, as
determined from consecutive CT sections. Patient 2 (Pt 2),
a female age 62 years, had a tumour mass of 37 and 56 g
in the left and right lobes, respectively, close to the vena
cava, liver veins, and the portal tract, with corresponding
normal liver parenchyma of 700 and 1,350 g, respectively.
Surgery was performed on both patients on the ninth day
after radioembolisation.Radioembolisation
The patients underwent selective hepatic artery angiog-
raphy followed by infusion of technetium-99m-labelled
macro-aggregated albumin (99mTc-MAA) to obtain infor-
mation about distribution to enable subsequent activity
prescription as well as ruling out excessive pulmonary
shunting [20]. When calculating BED, the following pa-
rameters were chosen: α/β = 2.5 Gy for the liver paren-
chyma and α/β = 10 Gy for the tumours. This is in
accordance with the calculations by Cremonesi et al. [13]
as well as with the recommendations given by Dale and
Jones [21] for tumour types with limited documentation
on radiosensitivity as well as repopulation rate, e.g. cholan-
giocarcinoma [22-25].
Two weeks later, the hepatic artery was recannulated
for infusion of the 90Y-labelled SIR-Spheres (Sirtex Med-
ical Limited, North Sydney, Australia). The microspheres
consist of polymer resin with a mean diameter of 30 μm
(20 to 60 μm), aggregated with the beta emitter 90Y, with
an approximate activity of 50 Bq (40 to 70 Bq) per
sphere. The mean and maximum ranges of the electrons
(mean energy, 0.934 MeV) in soft tissues are 2.5 and
11 mm, respectively. The half-life of 90Y is 64 h, so that
only 9% to 10% of the injected activity would remain at
the day of surgery. The number of spheres injected
during approximately an hour, together with 30 to 40 ml
distilled water, was about 50 billion (2.4 GBq) for Pt 1
and 30 billion (1.6 GBq) for Pt 2. The construction of
the application device will minimise the risk of micro-
sphere aggregations within the infusate [26-28].Surgery
The patients were re-admitted for surgery on the ninth
day post-radioembolisation. The surgical procedures,
performed by an experienced specialist (MR), targeted
removal of the macroscopic tumour mass to include a
rim of surrounding normal liver tissue when possible.
An ultrasonic cavitron aspirator was used for dissection.
Radiation safety issues during surgery were studied and
have been previously reported [29].
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The resected tissue was immediately immersed in 10%
neutral formaldehyde solution for 48 h and then ma-
chine sliced in sections approximately 1 to 8 mm thick
for Pt 1 and 1 to 2 mm thick for Pt 2. Every other slice
was covered in double layers of 0.2-mm plastic film and
exposed to autoradiography films (Amersham Hyperfilm®
MP, GE Healthcare, Uppsala, Sweden) in cassettes (for 5 h,
5 days after surgery for Pt 1 and 2 h, 3 days after surgery
for Pt 2). The remaining slices were punched in various
dimensions (diameters 3, 4, 6 and 8 mm): 8 to 422 mg for
Pt 1 and 5 to 102 mg for Pt 2. The biopsies were weighed
and immersed in 1 ml formaldehyde solution (formalin) in
plastic vials with an inner diameter of 9 mm and a wall
thickness of 1 mm. The activity was measured from the
bremsstrahlung in an automatic gamma well counter
(Wizard® 1480, PerkinElmer, Waltham, MA, USA), with
activity calibrated for 90Y in the same vial type and
liquid volume.
Analysis of heterogeneity
Apart from autoradiography, the coefficient of variation
(CV) of the activity concentration distribution in biop-
sies was studied. CV decreasing with increasing biopsy
volumes sizes shows a pattern of repetitive heterogeneity,
consistent with the repetitive structure of the liver paren-
chyma. CVs lacking this trend (sometimes decreasing,
sometimes increasing with increasing biopsy volume)
show a chaotic, irregular unstructured heterogeneity that
cannot be extended to a larger volume. A large variance of
biopsy volumes within the sample mass group could also
cause this effect. A strong negative trend with increasing
biopsy volume would indicate a heterogenic pattern with a
larger basic element size than the compared volumes. A
weak negative trend of consistently small CV values indi-
cates that the heterogenic pattern probably has smaller
elements than the biopsy volumes investigated. The ex-
planation for this is that almost all the expected variation
due to heterogeneity will be found within each biopsy and
the variance within a sample of biopsies would be ex-
plained by systematic variations (gradients in activity
concentrations) rather than variations caused by inter-
regional structure differences causing different distribution
patterns. The skewness (SK) of the distribution was calcu-
lated with the adjusted Fisher-Pearson standardised mo-
ment coefficient [30]:
SK ¼ n







A negative skew indicates many biopsies of low activity
(cold spots more common than hot spots), and a posi-
tive skew indicates the opposite, many biopsies of high
activity (hot spots more common than cold spots). Tostudy normal liver tissue by light microscopy, 10 serial
sections, each 20 μm thick, were prepared from each of
6 (circular diameters of 4 to 8 mm) normal liver biopsies of
Pt 2, resulting in a total of 60 slices. The biopsies were par-
affin embedded, sectioned and stained with haematoxylin
and eosin. Microspheres were counted and grouped by
studying sequential sections under light microscopy.
Results
SPECT/CT studies from the 99mTc-MAA infusions dis-
closed a pulmonary shunting of 3.0% and 3.5% for Pt 1
and Pt 2, respectively. The tumour-to-normal liver activ-
ity concentrations (TNCs), averaging voxel levels in the
entire tumours as well as entire normal liver tissues,
were calculated at 2.7 and 3.8 in Pt 1 and Pt 2, respect-
ively. The CVs were 0.29 (normal) and 0.42 (tumour) for
Pt 1 and 0.77 (normal) and 0.089 (tumour) for Pt 2.
From the pre-therapy studies, the prescribed activities
to be delivered would result in expected average doses
and BEDs to normal liver of 22 (BED = 29) Gy and 33
(BED = 49) Gy for Pt 1 and Pt 2, respectively. For prac-
tical reasons, the doses were averaged over both the por-
tions of normal tissue planned to be resected (tumour
margins) as well as the living liver tissue remaining in
the patient after surgery. The expected (if unresected)
doses to tumours (in accordance with TNC values re-
ported above) were calculated to 59 (BED = 67) Gy and
125 (BED = 161) Gy for Pt 1 and Pt 2, respectively.
Based on the measured activity in biopsies, the average
absorbed dose to normal liver parenchyma was calcu-
lated to 31 (BED = 45) Gy (620 Bq/mg) for Pt 1 and 52
(BED = 93) Gy (1,040 Bq/mg) for Pt 2. The correspond-
ing calculation based on tumour biopsies resulted in 100
(BED = 123) Gy (2,000 Bq/mg) for Pt 1 and 150 (BED =
202) Gy (3,050 Bq/mg) for Pt 2. Thus, based on the lim-
ited sample volumes, the TNCs were 3.2 and 2.9 for Pt 1
and Pt 2, respectively.
In Pt 2, different clustering patterns of the micro-
spheres were found with light microscopy, with several
clusters distributed through more than one serial sec-
tion. The seven largest clusters, of the type shown in
Figure 1B, ranged 22 to 59 microspheres when aligning
serial adjacent slices. Of the 240 locations found with
single or several microspheres, 154 were isolated single
spheres (Figure 1A), i.e. at a distance >200 μm (7 sphere
diameters) from the nearest neighbouring sphere. This
distance was chosen as it was consistent with the largest
portal tract found and therefore two single spheres
would not occupy the same portal tract. Thus, 64% of all
locations contained single isolated spheres, representing
only 19% of the total number of spheres; 53% of all 793
spheres were located within any of the 19 largest clusters
(7% of the locations), ranging 8 to 59 spheres per cluster





Figure 1 Light microscopy images illustrating the three main
types of microsphere aggregations found in Pt 2. (A) Single
isolated sphere in an arteriole in a small portal tract, magnified ×
200. (B) A large cluster of 27 spheres in a relatively large portal tract
with a wide arteriole, ×100. Based on adjacent slices, this cluster was
part of a cluster of 36 spheres.
Figure 2 Histogram reflecting the distribution of spheres
observed by microscopy in normal liver parenchyma of Pt 2.
Six biopsies from Pt 2, with a total volume of 36 mm3, divided into
60 slices were investigated. Bars show the number of clusters found
with each size, i.e. spheres per cluster. Fifty-three percent of all
793 spheres found were located within any of the larger clusters
(8 to 59 spheres/cluster).
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spheres is shown in Figure 2. The total activity found in the
six biopsies, divided by their total mass, showed an activity
concentration of 1,550 Bq/mg. The 793 spheres (50 Bq per
sphere) found in the 60 sections with a total volume of
36 mm3 showed an activity concentration of 1,120 Bq/mg
(28% lower).
Autoradiography
Images acquired through autoradiography, performed on
resected tumour and normal liver parenchyma, are shown
in Figure 3. The images indicate a heterogenic pattern,
with several hot and cold spots of radioactivity and a
generally higher activity concentration in tumour tissue.
Detector measurements
Tables 1, 2 and 3 show statistical data for the radioactiv-
ity distribution of Pt 1. No clear decreasing or increasing
trends are observable for CVs or SKs; however, the CVswere consistently lower for the left lobe, showing a
higher mean activity concentration.
Tables 4, 5 and 6 show the radioactivity distribution
data for Pt 2. Tables 4 and 5 show CV and SK decreasing
with increasing mass. A comparison of CV levels between
the tables shows a higher CV for normal liver parenchyma
at some distance from the tumour, compared to adjacent
to the tumour, consistent with differing mean activity
concentrations. Figure 4 shows histograms of the data
presented in Table 4.
Tumour tissue analysis revealed no clear trend of
decrease or increase with increasing biopsy volumes for
CVs and SKs (Table 6).
Discussion
In this study, surgical resection of tumours enabled a
detailed investigation of microsphere distribution. To
avoid haemorrhage and dissection difficulties along crit-
ical structures, surgery was performed before radiation-
induced inflammatory reactions developed. Late surgery
after inflammatory decline might have increased the risk
for extensive fibroses.
The current autoradiogram results, showing irregular
distributions and varying sizes of hot and cold spots of
radioactivity, are in line with previous studies, mainly
involving light microscopy evaluation of tissue samples
collected months after injection [14-17]. However, the
previous and current studies are of limited value for
Figure 3 Schematic overview of tissue samples and radiological methods. (A, C) Pt 1. (B, D) Pt 2. (A) and (C) show the same tissue slice,
with radiography in (A) and a photo scan in (C). The small region of (A) and (C), limited by the dotted red line, is normal liver parenchyma with
no visual signs of tumour involvement, as opposed to the larger tissue region on the other side of the line. The images to the left in (B) and (D)
show autoradiography and biopsy punching of normal liver tissue. The images to the right in (B) and (D) show likewise for tumour and normal
liver parenchyma without tumour involvement but adjacent to the tumour. The dotted red line in (B) and (D) limits the smaller tumour tissue
region from the adjacent normal liver parenchyma without visual signs of tumour involvement. (D) shows how several small tissue biopsies of
different sizes have been punched out, from the tissue slices being examined with autoradiography in (B), to measure their activity concentration.
For Pt 1, samples were also punched out from the slice shown in (C) but after photography.
Table 1 Activity distributions in normal liver tissue from






Mass (mg) 8 ≤m ≤ 41 47 ≤m ≤ 76 80 ≤m ≤ 422 8 ≤m ≤ 422
m (mg) 20 63 210 100
n 11 11 12 34
Spheres=biopsy 1,200 3,300 9,200 4,400
A=m (Bq/mg) 3,100 2,600 2,200 2,200
CV 0.45 0.46 0.41 0.46
SK −0.35 −0.52 −0.12 0.058
CV, coefficient of variation; m , mean mass of n tissue biopsies; Spheres=biopsy,
average number of spheres per biopsy; A= m , mean activity concentration;
SK, skew of the distribution.
Table 2 Activity distributions in normal liver tissue from








Mass (mg) 12≤m≤ 62 63≤m≤ 125 128≤m≤391 12≤m≤ 391
m (mg) 39 82 240 120
n 22 20 20 62
Spheres=biopsy 510 740 2,200 1,200
A=m (Bq/mg) 670 450 470 480
CV 0.63 0.67 0.57 0.65
SK 0.27 2.8 1.7 1.2
CV, coefficient of variation; m , mean mass of n tissue biopsies; Spheres=biopsy,
average number of spheres per biopsy; A= m , mean activity concentration;
SK, skew of the distribution.
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Table 3 Activity distributions in tumour tissue of Pt 1
Liver lobe
Left Right
Mass (mg) 15 ≤m ≤ 26 54 ≤m ≤ 104 49 ≤m ≤ 73 76 ≤m ≤ 90
m (mg) 21 75 60 82
n 16 16 9 9
Spheres=biopsy 1,500 3,000 1,100 980
A=m (Bq/mg) 3,600 2,000 910 610
CV 0.49 0.75 0.66 0.51
SK −0.46 0.82 1.0 0.64
CV, coefficient of variation; m , mean mass of n tissue biopsies; Spheres=biopsy,
average number of spheres per biopsy; A= m , mean activity concentration;
SK, skew of the distribution.
Table 5 Activity distributions in normal liver tissue








Mass (mg) 5 ≤m ≤ 14 16 ≤m ≤ 41 43 ≤m ≤ 102 5 ≤m ≤ 102
m (mg) 10 27 69 35
n 26 24 25 75
Spheres=biopsy 380 920 2,300 1,200
A=m (Bq/mg) 1,900 1,700 1,700 1,700
CV 0.81 0.58 0.45 0.64
SK 1.8 1.2 0.69 1.9
CV, coefficient of variation; m , mean mass of n tissue biopsies; Spheres=biopsy,
average number of spheres per biopsy; A= m , mean activity concentration;
SK, skew of the distribution.
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spheres, because serially aligned sections have to be
prepared and carefully analysed, which was done in
limited volume in this study. We also applied a less
time-consuming new approach for analysing clustering
size and its distributions.
Our approach to studying the geometric pattern of non-
uniformity relied on measurements of activity concentra-
tion in tissue samples of various sizes. With this approach,
the SK and CV should decrease with increasing biopsy size
for heterogenic patterns with larger basic elements than the
biopsy sizes.
The difference between TNCs, comparing imaging and
biopsy measurements, can be explained by the fact that
the latter method excludes averaging over the tissue left
in the patient after surgery and that tumour tissue domi-
nated the resected volume of Pt, whereas resected nor-
mal liver parenchyma dominated for Pt 2.
In Pt 1, the mean activity concentration decreased
with increasing masses, but CVs and SKs did not follow
the expected trend. These results indicate that the mass
groups probably were too wide and mean masses mayTable 4 Activity distributions in normal liver tissue far








Mass (mg) 6 ≤m ≤ 14 15 ≤m ≤ 39 40 ≤m ≤ 91 6 ≤m ≤ 91
m (mg) 10 27 66 35
n 29 26 29 84
Spheres=biopsy 300 590 1,200 740
A=m (Bq/mg) 1,500 1,100 900 1,000
CV 1.4 1.0 0.63 1.3
SK 3.0 1.8 0.82 4.0
CV, coefficient of variation; m , mean mass of n tissue biopsies; Spheres=biopsy,
average number of spheres per biopsy; A= m , mean activity concentration;
SK, skew of the distribution.have been too large. Mass homogeneity of each mass
group thus appears statistically important; furthermore,
the number of biopsies might have been too low.
The normal liver parenchyma consists of a very well
structured distribution of more than one million lobules
and associated portal tracts. Each lobule is associated
with six portal tracts, but because of the hexagonal
arrangement of lobules, three lobules share each portal
tract. Therefore, there are no more than two portal
tracts per lobule throughout the parenchyma. A lobule
weighs around 2 mg, so there is about one portal tract
per milligram of liver tissue [31]. Considering the portal
tracts as the target site for microspheres, the number of
target sites in the sample sizes from Pt 1 could range
from 8 to 62 in the smallest sample groups to over 400
in the largest. To identify any spatial variation in cluster
frequency, the sample sizes must include few targets
with a low variation in mass.
The results from Pt 2 with many biopsies and smaller
masses with a low variation in mass showed a clear
trend consistent with the heterogeneity of normal liver








Mass (mg) 5 ≤m ≤ 11 12 ≤m ≤ 37 38 ≤m ≤ 95 5 ≤m ≤ 95
m (mg) 8.4 23 65 32
n 14 14 13 41
Spheres=biopsy 690 2,100 3,100 1,900
A=m (Bq/mg) 4,100 4,500 2,400 3,000
CV 0.50 0.71 0.36 0.65
SK 0.78 2.9 −1.3 2.8
CV, coefficient of variation; m , mean mass of n tissue biopsies; Spheres=biopsy,
average number of spheres per biopsy; A= m , mean activity concentration;




























Figure 4 Activity concentration histograms reflecting
distributions in biopsies of normal liver parenchyma of Pt 2.
Bars show the number of samples for each interval. Each histogram
is split into ten activity intervals, giving different bar widths
depending on the maximum activity identified. The histograms
reflect biopsies at a relatively large distance from the tumour but
with different mass intervals: (A) masses 6 to 14 mg, (B) masses 15
to 39 mg and (C) masses 40 to 91 mg.
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CV indicates that the basic element of the heterogenic
pattern is larger than or similar in size to the biopsies in
the group with the largest masses (about 70 mg). The de-
creasing positive SK indicates a rather frequent and repeti-
tive presence of hot spots of radioactivity, i.e. microsphere
clusters or regional gatherings. The small sample investi-
gated by light microscopy showed a similar and slightly
higher CV (2.1) and SK (4.9) than was identified by activity
measurements on the sample group of origin (CV of 1.3
and SK of 4.0; Table 4). These findings seem to agree
with the repetitive microscopic vascularisation structure
of the liver. As only 8% of the total volume of the six
biopsies selected for microscopic studies were in fact
investigated in microscope, it is not surprising that the
activity concentration differed with 28% comparing
sphere counting in microscope with detector measure-
ments on the same six biopsies.
Comparison of the two normal tissue regions showed
a lower CV with higher activity concentration and simi-
lar masses. This finding indicated decreasing heterogen-
eity with increased activity concentration.
In contrast to normal liver parenchyma, tumour tissue
architecture is unstructured, with scattered fibrotic and
necrotic areas that obviously influence the statistical re-
sults. The current inconclusive results for tumour tissue
are included only to highlight how our method, when
applied correctly (e.g. for Pt 2), could distinguish a struc-
tured heterogenic distribution (normal liver parenchyma)
from a more chaotic heterogenic distribution (tumour).
These findings are in accordance with those of Tveit et al.
who studied the regional perfusion ex vivo in human
kidney specimens, including carcinomas. They found a
homogeneous high perfusion in the well-structured renal
cortex in contrast to the highly inhomogeneous perfusion
in the tumour tissue [32]. The results for normal liver
tissue are based on a comparatively large number of tissue
biopsies: 96 from Pt 1 and 159 biopsies of Pt 2, supporting
our conclusions.
Limited data on microsphere distribution in patients
are available. Some efforts have targeted dosimetric
calculations, and studies mainly have been light micros-
copy investigations of tissue samples collected months
after administration [15-17,33,34]. The reported results
are consistent with ours, showing large heterogeneities
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effects and also heterogeneity patterns that are more
prominent in normal liver tissue than in tumour tissue.
Gulec et al. simulated dose distributions in the context
of liver tissue microanatomy and showed different mean
absorbed doses to different tissue structures [18]. How-
ever, they noted that they never intended to consider the
expected heterogeneities in the distribution of micro-
spheres; thus, the assumed homogeneous distribution
resulted in different mean doses between different struc-
ture types, but basically no variance within structure
types. Applying our findings of heterogeneities on a large
scale could be clinically valuable, comparing them to the
size of individual liver lobules used as the fundamental
unit in their simulations and showing a more realistic dose
variance within specific structure types. Our findings
suggest that some lobules may receive very few or no
microspheres whereas others may receive large clusters or
strings of spheres. Indeed, larger clusters of microspheres
might be stuck within larger arterioles, limiting the mean
absorbed dose to finer liver structures, such as within the
liver lobules.
Recently, Walrand et al. simulated different arterial tree
models, varying the parameters affecting the distribution
of glass microspheres [35]. Their results showed heteroge-
neities and clustering of spheres due to stochastic and sys-
tematic variations of the blood flow. Their clusters tended
to be much smaller. The majority of the spheres were
found within clusters of two to three spheres, about 30%
to 40% were found to be single spheres, 10% of the spheres
were found within clusters of four to five spheres and only
a few percent within cluster sizes of seven to ten spheres.
The explanation for this could be that the 25 times lower
specific activity per resin sphere, as compared to glass
spheres, and thus a much higher number of resin spheres
injected, tends to create larger clusters, for statistical rea-
sons. This would be consistent with the results from our
study, with the majority of the spheres trapped within
cluster sizes of 8 to 59 spheres. It is also possible that the
more extensive embolisation caused by higher numbers of
resin spheres has a more dramatic effect on the arterial
circulation, causing larger differences in blood flow and
thus larger inter-regional variations in distributions of mi-
crospheres, making the mentioned model less applicable
for resin spheres.
We studied heterogeneity on a scale slightly larger
than the mean range of β− electrons from 90Y. Interest-
ingly, the CVs for activity distributions are higher within
limited regions, as measured on biopsies, than in entire
tissue volumes, as measured with 99mTc-MAA. Even
though the 99mTc-MAA gamma radiation is smeared
out, the homogenising effect of crossfire between mi-
crospheres will not smooth heterogeneity at this scale
(the aim in treating tumour tissue, but unwanted innormal liver parenchyma), as the mean range of the 90Y
beta radiation is only 2.5 mm. The statistical methods
used here demonstrate activity heterogeneity at a thera-
peutically relevant geometric scale, which might be use-
ful for protocol optimisation. In their modelling study,
Cremonesi et al. showed that liver tissue might be
spared by fractionated administration of microspheres
[13]. In such calculations, however, the sparing effect
arises only from a decreased dose rate. Our results
indicate that the heterogeneity of microsphere trapping
between fractions might heighten the sparing effect of
fractionation protocols.
To obtain a more precise dosimetric distribution from
our results, the heterogenic distribution of activity must
be applied to a detailed 3-D activity distribution matrix
model, convolved with a 3-D beta dose kernel matrix, to
plot reliable dose-distribution histograms for input in
response models such as the BED model.
Conclusions
Tissue activity distributions in normal tissue were heteroge-
neous on a relevant geometric scale considering the mean
range of the ionising electrons. Given the similar and re-
petitive structure of the liver parenchyma within and be-
tween patients, the detected heterogeneities in normal liver
parenchyma can partly explain the survival of normal tissue
in regions receiving a substantially higher mean absorbed
dose than could be tolerated with more homogeneous dose
distributions resulting from external radiation techniques.
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